Insulin-responsiveness of tumor growth

Archives of Physiology and Biochemistry

Volumn 115, Issue 2, 2009, Pages 47-48

  Chantelau, Ernst ^a  

^a Endocrinology Practice Dr Kimmerle   (Germany)

Author keywords

Cancer; Growth factors; Insulin

Indexed keywords

ANIMALIA;

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; SOMATOMEDIN C RECEPTOR;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; DRUG EFFECT; GERMANY; HUMAN; METABOLISM; MITOSIS; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; GERMANY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MITOSIS; RECEPTOR, IGF TYPE 1;

EID: 68149154617     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802709029     Document Type: Review

References (4)

1. Berger MR, Fink M, Feichter GE, Janetschek P. 1985. Effects of diazoxide- induced reversible diabetes on chemically induced autochthonous mammary carcinomas in Sprague- Dawley rats. Int J Cancer 35:395-401.
2. Eckardt K, Eckel J. 2008. Insulin analogues: action profiles beyond glycaemic control. Arch Physiol Biochem 114:45-53.
3. Huggins C. 1966. Endocrine-induced regression of cancers. Nobel Lecture, December 13, 1966. http://nobelprize.org/nobel-prizes/medicine/laureates/1966/ hugginslecture.pdf.
4. Osborne CK, ZBolan G, Monaco ME, Lippman ME. 1976. Hormone responsive human breast cancer in longterm culture: Effect of insulin. Proc Natl Acad Sci USA 43:4536-4540.